Evaluation of effect of chromium compounds
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Metabolic syndrome patients
- Registration Number
- CTRI/2017/08/009519
- Lead Sponsor
- DrCGayatri Devi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 117
Inclusion Criteria
1.endothelial dysfunction defined as <= 6% change in reflection index (RI) on post salbutamol challenge test and according to â??The International Diabetes Federationâ?? guidelines
Exclusion Criteria
Patients with severe uncontrolled hyperglyceamia, uncontrolled hypertension, cardiac arrhythmia, impaired hepatic or renal function, history of malignancy or stroke, smoking, chronic alcoholism, any other serious disease requiring active treatment and treatment with any other herbal supplements
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method